COVID-19 vaccine development: Time to consider SARS-CoV-2 challenge studies?
Abstract
While a human challenge study holds the prospect of accelerating the development of a vaccine for the coronavirus SARS-CoV-2, it may be opposed due to risks of harm to participants and researchers. Given the increasing number of human deaths and severe disruption to lives worldwide, we argue that a SARS-CoV-2 challenge study is ethically justifiable as its social value substantially outweighs the risks. Such a study should therefore be seriously...
Paper Details
Title
COVID-19 vaccine development: Time to consider SARS-CoV-2 challenge studies?
Published Date
Jul 1, 2020
Journal
Volume
38
Issue
33
Pages
5085 - 5088
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History